R406.

Seth Warner1, Heather L Teague1, Marcos J Ramos-Benitez2

  • 1Critical Care Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA; Critical Care Medicine Department, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD, USA.

Cellular immunology
|July 31, 2024
PubMed
概括

福斯塔马提尼布的活性代谢物R406在败血症模型中有效抑制有害的中性粒细胞反应. 这表明fostamatinib可能是通过控制中性粒细胞过活化的细菌性败血症的有希望的治疗方法.